Pharmaceutical lactose monohydrate · The pharmacopoeial tests (water 4.5–5.5%, specific optical rotation, heavy metals, sulfated ash, microbial limits) plus the functionality characteristics buyers set by grade: milled, sieved, spray-dried or inhalation lactose, particle size, bulk and tapped density
Lactose monohydrate is a milk sugar excipient used as a filler or diluent in tablets, capsules and powders. Pharmaceutical grades must meet a pharmacopoeia monograph and are supplied in different physical forms, such as milled, sieved, spray-dried or inhalation grades, that behave differently in processing. Ask three things first: which pharmacopoeias the grade must meet, which physical grade suits the process, and which particle size and density values must be controlled.
Alpha-lactose monohydrate excipient grades for oral solid dosage forms, specified to pharmacopoeia monographs and by functional characteristics. Anhydrous lactose, food or feed lactose, and other excipients are outside this page.
01
The Ph. Eur. monograph 0187 for lactose monohydrate, as reproduced in the British Pharmacopoeia 2013, defines O-β-D-galactopyranosyl-(1→4)-α-D-glucopyranose monohydrate, C12H22O11·H2O, Mr 360.3, CAS 10039-26-6, as a white or almost white crystalline powder, freely but slowly soluble in water and practically insoluble in ethanol, used as an excipient. [1]
Its tests include specific optical rotation of +54.4 to +55.9 (anhydrous substance); an acidity limit of not more than 0.4 mL of 0.1 M sodium hydroxide for 6.0 g; absorbance limits at 400 nm and 210–300 nm; heavy metals at most 5 ppm; water 4.5–5.5% by Karl Fischer; sulfated ash at most 0.1%; total aerobic microbial count (TAMC) acceptance criterion 10² CFU/g; and absence of Escherichia coli. It is to be stored in an airtight container. [1]
The monograph's non-mandatory functionality-related characteristics for lactose used as a filler or diluent in compressed and powder dosage forms are particle size distribution and bulk and tapped density, with the Hausner index calculated from them. [1] Check which edition and which pharmacopoeias (Ph. Eur., USP-NF, JP, ChP) your filing requires, since this source is the 2013 text.
Give the supplier the pharmacopoeias and editions to be met, the physical grade and particle size distribution, bulk and tapped density targets, any nitrite, endotoxin or elemental impurity requirements, packaging, retest period, documentation (certificate of analysis, regulatory statements) and annual volume.
02
MEGGLE describes its GranuLac 200 as a milled 200-mesh alpha-lactose monohydrate meeting Ph. Eur., USP-NF, JP and ChP, with fine, sharp-edged, cohesive particles for wet and dry granulation, blends, premixes, sachets and triturations. It says milled lactose, being brittle, consolidates "primarily by fragmentation" but has limited flowability, so it should be granulated before tableting where possible, and that its narrow particle size distribution and controlled density help tune tabletability and compressibility. [2]
MEGGLE lists GranuLac 200 for capsules, sachets and tablets, packed as 25 kg paper bags with a PE-EVOH-PE inliner, with a 36-month retest period, made in Wasserburg am Inn, Germany, and supplies statements on elemental impurities, nitrosamines, microbial testing and other compliance topics. Its range also includes sieved, spray-dried, direct-compression, dry powder inhalation and low-endotoxin lactose grades. [2]
Editorial calculation: a TAMC criterion of 10² CFU/g is 100 CFU per gram; a 36-month retest period is 3 years. [1] [2]
03
A 2011 Universiti Putra Malaysia study in Drug Design, Development and Therapy measured two lactose grades used as filler-binder: lactose 100M had a mean particle size of 118 µm, poured density 0.73 g/mL, tapped density 0.88 g/mL, Hausner ratio 1.21 and Carr's index 17% (flow rated fair), while lactose 200M had 49 µm, 0.54 g/mL, 0.80 g/mL, Hausner ratio 1.47 and Carr's index 33% (flow rated poor). [3]
Blending these with ascorbic acid and zinc oxide in a convective ribbon mixer at 40, 60 and 80 rpm for 5 to 25 minutes, the authors found that with preblending the 200M mixture reached the required homogeneity sooner and at a lower rotational speed; they attribute this to the fine 200M particles adhering to the larger ascorbic acid particles and limiting segregation, while the freer-flowing 100M needed longer. All mixtures met the homogeneity requirement after 25 minutes at the lowest speed tested, and the authors warn that prolonged high-speed mixing leads to segregation. [3]
Editorial calculation: the Hausner ratio is tapped over poured density, 0.88 ÷ 0.73 ≈ 1.21 and 0.80 ÷ 0.54 ≈ 1.48, consistent with the published 1.21 and 1.47 — the bulk and tapped densities that monograph 0187 lists as functionality-related characteristics. The fine grade's poor flow matches MEGGLE's advice to granulate milled 200-mesh lactose before tableting. Ask suppliers for PSD, bulk and tapped density measured on the lot, not only a grade name. [3] [1] [2]
04
Ask any supplier for the pharmacopoeias met, the specified particle size distribution and lot results, bulk and tapped density, water, microbial and elemental impurity results, GMP or EXCiPACT certification, change-control policy, packaging, retest period and lead time.
05
DFE Pharma's product page for Pharmatose 200M describes a pure, white, crystalline, milled lactose monohydrate for filler-binder, diluent and binder use in tablets and capsules, with wet granulation, extrusion spheronization and continuous processing as recommended processes. Under the heading "Typical product data" it gives particle size x10 5 µm, x50 35 µm and x90 100 µm, bulk density 0.60 g/mL and Hausner ratio 1.41. It lists 25 kg paper bags, 50 kg drums and 500–1,000 kg big bags, a 36-month shelf life, production in Veghel, the Netherlands, and a downloadable product specification, ICH Q3D statement and certificate of suitability. [4]
Editorial calculation: tapped density is bulk density × Hausner ratio, 0.60 × 1.41 ≈ 0.85 g/mL. The 2011 study's lactose 200M had a 49 µm mean size, 0.54 g/mL poured density and a Hausner ratio of 1.47; the study does not name the maker, and x50 is a median, not a mean, so the figures are not a like-for-like comparison. [4] [3]
Editorial note: DFE lists these under "Typical product data", not as limits. Ask for the product specification sheet and the lot certificate with the PSD method, and agree which x10, x50, x90 and density limits apply to your order. [4] [1]
06
Four of the six rows are monograph 0187 tests with fixed limits; particle size and density are its non-mandatory functionality characteristics, which the supplier's grade and lot data have to cover. [1]
| Requirement | What it controls | Fix in the order |
|---|---|---|
| Identity and optical rotation | Confirms lactose monohydrate. [1] | Pharmacopoeia. |
| Water (Karl Fischer) | Monohydrate water content. [1] | 4.5–5.5%. |
| Heavy metals and ash | Inorganic impurities. [1] | Limits. |
| Microbial limits | TAMC and E. coli. [1] | Criteria. |
| Particle size and density | Flow, blending, compaction. [1] [2] | PSD; bulk; tapped. |
| Physical grade | Milled, sieved, spray-dried, inhalation. [2] | Grade for process. |
07
Water 4.5–5.5%, heavy metals at most 5 ppm and sulfated ash at most 0.1% are fixed by the monograph; loss on drying, pH and assay are not in the reviewed text, which uses Karl Fischer water and an acidity titration instead. [1]
| Field | What it means and published values | Ask the supplier for |
|---|---|---|
| Particle Size D90 (μm) | PSD is a functionality characteristic; 200 mesh milled grade offered. [1] [2] | D10/D50/D90. |
| Loss on Drying (%) | Not in the reviewed monograph text; water by KF instead. [1] | If required. |
| Bulk Density (g/mL) | Functionality characteristic; e.g. 0.73 (100M) and 0.54 g/mL (200M) poured in one study. [1] [3] | Value. |
| Tapped Density (g/mL) | Functionality characteristic; Hausner index; e.g. 0.88 and 0.80 g/mL, Hausner 1.21 and 1.47. [1] [3] | Value. |
| pH Value (pH) | Acidity limit by titration instead. [1] | Result. |
| Heavy Metals Content (ppm) | At most 5 ppm. [1] | Result or ICH Q3D statement. |
| Assay (as C12H22O11·H2O) (%) | Not stated in the reviewed monograph text. | Assay if required. |
| Specific Optical Rotation (°) | +54.4 to +55.9 (anhydrous). [1] | Result. |
| Microbial Purity (TAMC) (CFU/g) | 10² CFU/g; absence of E. coli. [1] | Result. |
| Total Ash (%) | Sulfated ash at most 0.1%. [1] | Result. |
| Water Content (KF) (%) | 4.5–5.5%. [1] | Result. |
| Organic Volatile Impurities (%) | Not stated in the reviewed sources. | Statement. |
| Solubility (water) | Freely but slowly soluble in water. [1] | — |
08
Paste it into your enquiry below or into an email to a maker, then replace every bracket.
Pharmacopoeias: [Ph. Eur.; USP-NF; JP; ChP; edition] Grade: [milled; sieved; spray-dried; inhalation] PSD: [D10; D50; D90] Density: [bulk; tapped] Extras: [low nitrite; low endotoxin] Packaging: [25 kg bag; liner] Documents: [CoA; statements] Volume: [t per year]
Manufacturer profiles associated with Pharmaceutical-Grade Lactose Monohydrate.
Explore company information and manufacturing capabilities, then discuss the scope of your project with a relevant supplier.
The Ph. Eur. monograph 0187 text reviewed sets 4.5 to 5.5% by Karl Fischer. [1]
The monograph lists particle size distribution and bulk and tapped density as functionality characteristics. [1]
MEGGLE says its milled 200-mesh GranuLac 200 suits wet and dry granulation but has limited flowability. [2]
In a 2011 study lactose 100M (118 µm) had a Hausner ratio of 1.21 and fair flow, while lactose 200M (49 µm) had 1.47 and poor flow. [3]
DFE Pharma's Pharmatose 200M page gives x10 5 µm, x50 35 µm and x90 100 µm, bulk density 0.60 g/mL and a Hausner ratio of 1.41 (typ.). [4]
Sources checked 2026-10-11. The British Pharmacopoeia reproduces the Ph. Eur. lactose monohydrate monograph; MEGGLE makes pharmaceutical lactose; the Universiti Putra Malaysia paper measured flow and blending of two lactose grades.
Ask for use case, specification boundaries, supplier type, and RFQ preparation information for this product.
Compare manufacturer profiles with relevant product and process capability.